Clarity Pharmaceuticals awarded $300,000 in Commercialisation Australia Grant funding
5 December 2011 Clarity Pharmaceuticals has been awarded two Commercialisation Australia grants totalling $300,000. The “Skills and Knowledge” and “Proof of Concept” grants will help Clarity provide its PET imaging agents and services for human clinical studies, and aid in Clarity’s diagnostic development program. The funding will directly contribute to a clinical trial validating one…